Treatment Guidelines Materials

This fact sheet provides information regarding the 12-dose regimen for treating latent TB infection.

This document describes the steps necessary to implement the shorter regimen and the new drugs for drug-resistant TB treatment, including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation.

This Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

This session focuses on hepatitis B global epidemiology, as well as hepatitis D testing, management and treatment. This interactive session discusses how we can work together to improve awareness and testing for HBV co-infection.

The National STD Curriculum is a free educational Web site from the University of Washington STD Prevention Training Center and the University of Washington. This project is funded by a grant from the Centers for Disease Control and Prevention (CDC). The National STD Curriculum addresses the epidemiology, pathogenesis, clinical manifestations, diagnosis, management, and prevention of STDs. Free CME credit and free CNE credit are offered throughout the site.

This book presents information about implementing, maintaining, and evaluating respirator protection programs in health care facilities.

This manual provides information about TB program reviews and planning and technical support. It provides a view of international partnership towards the goal of eliminating TB.

This manual provides a structured plan for the training, development and evaluation of healthcare workers involved in contact investigation. It focuses on interview techniques and communication skills and provides data collection instruments for the provision of objective feedback to the interviewer.

This guideline presents updated data about drug interactions between protease inhibitors and non-nucleoside reverse transcriptase inhibitors for treatment of HIV infection together with rifamycins for treatment of TB.

This notice explains that on September 30, 1999, the Food and Drug Administration approved a reformulated amplified Mycobacterium Tuberculosis Direct (MTD) test for detection of Mycobacterium tuberculosis in acid-fast Bacille (AFB) smear-positive and smear-negative respiratory specimens from patients suspected of having TB.